Engineering metabolism to modulate immunity

Adv Drug Deliv Rev. 2023 Nov 5:115122. doi: 10.1016/j.addr.2023.115122. Online ahead of print.ABSTRACTMetabolic programming and reprogramming have emerged as pivotal mechanisms for altering immune cell function. Thus, immunometabolism has become an attractive target area for treatment of immune-mediated disorders. Nonetheless, many hurdles to delivering metabolic cues persist. In this review, we consider how biomaterials are poised to transform manipulation of immune cell metabolism through integrated control of metabolic configurations to affect outcomes in autoimmunity, regeneration, transplant, and cancer. We emphasize the features of nanoparticles and other biomaterials that permit delivery of metabolic cues to the intracellular compartment of immune cells, or strategies for altering signals in the extracellular space. We then provide perspectives on the potential for reciprocal regulation of immunometabolism by the physical properties of materials themselves. Lastly, opportunities for clinical translation are highlighted. This discussion contributes to our understanding of immunometabolism, biomaterials-based strategies for altering metabolic configurations in immune cells, and emerging concepts in this evolving field.PMID:37935318 | DOI:10.1016/j.addr.2023.115122
Source: Advanced Drug Delivery Reviews - Category: Drugs & Pharmacology Authors: Source Type: research